ClinicalTrials.gg
RecruitingNCT06190873Updated Jan 5, 2024

The Effect of Telephone Education on Fear of Movement and Quality of Life in Patients With Lumbar Disc Herniation Surgery.

An interventional study of post-discharge rehabilitation training in Spine Disease and Spinal Deformity, sponsored by Çanakkale Onsekiz Mart University. Recruiting at 1 site in Turkey. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-01-05.

Sponsored by Çanakkale Onsekiz Mart University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Primary completion was expected by Jan 2025, 1 year 10 months ago, but the record still lists the study as recruiting.
  • Started Dec 2023; still recruiting 2 years 11 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The aim is to quantify the fear of movement and quality of life of telephone education on lumbar disc herniation surgery.

Read the detailed description

In the randomized controlled study, patients will be randomized into two categories: experimental and control groups. The experimental group will receive intervention via online information for 6 weeks after discharge. The control group will not be given online training other than standard nursing care. At the end of 6 weeks, the difference between fear of movement and quality of life between the two groups will be examined.

02

Conditions studied

  • Spine Disease
  • Spinal Deformity

Browse trials for

Keywords

  • life quality
  • telehealty
  • tele nursing
  • kinezyofobi
03

In context

Spinal Diseases

174 studies on the registry are indexed under Spinal Diseases; 39 are open to participants now.

This study's planned enrollment of 80 is above the median of 60 across 106 interventional studies indexed under Spinal Diseases.

Browse Spinal Diseases studies →

Lead sponsor

Çanakkale Onsekiz Mart University is the lead sponsor of 51 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • being over 18 years old
  • knowing how to read and write Turkish
  • No hearing or speech impairment
  • Having lumbar disc herniation surgery for the first time
  • having a personal cell phone
  • being discharged 5 days after surgery

Exclusion criteria

Exclusion Criteria:

  • being under 18 years old
  • being illiterate
  • having a hearing and speech disability
  • not having a personal cell phone
  • staying in the hospital for more than 5 days after surgery
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    group to be trained over the phone

    This group will be trained by phone for 6 weeks after discharge.

    Behavioral: post-discharge rehabilitation training

  • No intervention
    Group without telephone training

    This group will be given training during their stay in the hospital. There will be no training over the phone after discharge.

Interventions

  • Behavioralpost-discharge rehabilitation training

    Telephone training will be provided for post-discharge rehabilitation

    Also known as: nursingcare, nursing education

06

What researchers measure

Primary outcomes

  1. movement fear scale

    In the measurement to be made with a four-point Likert type scale, 17 is the lowest score and 68 is the highest score. The higher the score the patient receives, the greater the fear of movement.

    Time frame: six week

Secondary outcomes

  1. quality of life scale

    The score obtained from the scale varies between 0 and 100. As the score obtained from the scale increases, the patient's quality of life increases.

    Time frame: six week

07

Study locations

1 of 1 sites recruiting
  • Çanakkale Mehmet Akif Ersoy Devlet Hastenesi
    Çanakkale, 17100, Turkey
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2023 (actual). Primary completion is estimated for Jan 2025, 13 months after the start.

Of 40 non-industry interventional studies with no phase under Spinal Diseases, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 50. This study's planned 13 months is below that.

Counting every sponsor, half of 43 studies reached it within 26 months; a quarter within 16 and three quarters within 60.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 11, 2023
First posted
Jan 5, 2024
StartActual
Dec 1, 2023
Primary completionEst.
Jan 1, 2025
CompletionEst.
Jan 1, 2025
Last update
Jan 5, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 5, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06190873
Lead sponsor
Çanakkale Onsekiz Mart University
Responsible party
Nilgün Temel (graduate student, Çanakkale Onsekiz Mart University) — Principal investigator
First posted
Jan 5, 2024
Start date
Dec 1, 2023
Primary completion
Jan 1, 2025 (estimated)
Completion
Jan 1, 2025 (estimated)
Last update
Jan 5, 2024

Study contacts

Nilgun Temel
Contact
nilgun.yavas91@gmail.com
05466520892

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion